Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Publications / Correlates of cervical mucosal antibodies to human papillomavirus 16: results from a case control study.

Correlates of cervical mucosal antibodies to human papillomavirus 16: results from a case control study.

  • Bierl C
  • Karem K
  • Poon AC
  • Swan D
  • Tortolero-Luna G
  • Follen M
  • Wideroff L
  • Unger ER
  • Reeves WC

16229879

Gynecol. Oncol.. 2005 Dec 99 (3 Suppl 1).

While the cervical mucosal immune response to human papillomavirus (HPV) infection is believed to be central to viral clearance, it is not well characterized. We performed this analysis to determine correlates of HPV-16-specific mucosal antibody response in women at high risk for infection with HPV.

Cervical mucosal and serum samples were obtained from participants in a case control study that measured demographic risk factors of cervical disease and HPV infection. An HPV-16 L1-virus-like particle ELISA was used to detect HPV-16-specific IgA and IgG. Antibody level results were correlated with demographic characteristics, sexual history, cervical disease, and HPV detection.

Cervical anti-HPV-16 IgA and IgG inversely correlated with HPV DNA, HPV-16 DNA, and cervical disease.

These findings suggest that mucosal antibodies may protect against HPV infection and cervical disease. However, additional longitudinal studies evaluating serum and mucosal antibody correlates of incident, persistent, and clearing HPV infection are needed. In addition, standardization of mucosal sample collection and testing methods are required.